These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8682132)

  • 1. Estimated gain in life expectancy. A simple tool to select optimal reperfusion treatment in individual patients with evolving myocardial infarction.
    Boersma H; van der Vlugt MJ; Arnold AE; Deckers JW; Simoons ML
    Eur Heart J; 1996 Jan; 17(1):64-75. PubMed ID: 8682132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reperfusion therapy for acute myocardial infarction. Which strategy for which patient?
    Boersma E; Steyerberg EW; Van der Vlugt MJ; Simoons ML
    Drugs; 1998 Jul; 56(1):31-48. PubMed ID: 9664197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptokinase. A pharmacoeconomic appraisal of its use in the management of acute myocardial infarction.
    Gillis JC; Goa KL
    Pharmacoeconomics; 1996 Sep; 10(3):281-310. PubMed ID: 10163575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three life years gained after reperfusion therapy in acute myocardial infarction: 25-30 years after a randomized controlled trial.
    Domburg RT; Hendriks JM; Kamp O; Smits P; Melle Mv; Schenkeveld L; Bax JJ; Simoons ML
    Eur J Prev Cardiol; 2012 Dec; 19(6):1316-23. PubMed ID: 22013152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction.
    Zijlstra F; de Boer MJ; Beukema WP; Liem AL; Reiffers S; Huysmans D; Hoorntje JC; Suryapranata H; Simoons ML
    Eur Heart J; 1996 Mar; 17(3):382-7. PubMed ID: 8737211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained benefit 20 years after reperfusion therapy in acute myocardial infarction.
    van Domburg RT; Sonnenschein K; Nieuwlaat R; Kamp O; Storm CJ; Bax JJ; Simoons ML
    J Am Coll Cardiol; 2005 Jul; 46(1):15-20. PubMed ID: 15992629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health and cost consequences of early versus late invasive strategy after thrombolysis for acute myocardial infarction.
    Bøhmer E; Kristiansen IS; Arnesen H; Halvorsen S
    Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):717-23. PubMed ID: 21450598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selecting the most appropriate reperfusion therapy for acute myocardial infarction. How useful are guidelines?
    van de Werf F
    Eur Heart J; 1996 Jan; 17(1):3-4. PubMed ID: 8682127
    [No Abstract]   [Full Text] [Related]  

  • 9. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.
    Krumholz HM; Pasternak RC; Weinstein MC; Friesinger GC; Ridker PM; Tosteson AN; Goldman L
    N Engl J Med; 1992 Jul; 327(1):7-13. PubMed ID: 1598117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.
    Mark DB; Hlatky MA; Califf RM; Naylor CD; Lee KL; Armstrong PW; Barbash G; White H; Simoons ML; Nelson CL
    N Engl J Med; 1995 May; 332(21):1418-24. PubMed ID: 7723799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptable reperfusion delay to prefer primary angioplasty over fibrin-specific thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not fit all.
    Tarantini G; Razzolini R; Napodano M; Bilato C; Ramondo A; Iliceto S
    Eur Heart J; 2010 Mar; 31(6):676-83. PubMed ID: 19946106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status.
    De Luca G; Suryapranata H; Marino P
    Prog Cardiovasc Dis; 2008; 50(5):352-82. PubMed ID: 18313480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitated percutaneous coronary intervention (PCI) in patients with acute ST-elevation myocardial infarction: comparison of prehospital tirofiban versus fibrinolysis before direct PCI.
    Möckel M; Bocksch W; Strohm S; Kühnle Y; Vollert J; Nibbe L; Dietz R
    Int J Cardiol; 2005 Aug; 103(2):193-200. PubMed ID: 16080980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of reperfusion strategies.
    Parmley WW
    Am Heart J; 1999 Aug; 138(2 Pt 2):S142-52. PubMed ID: 10426873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost and quality of life: thrombolysis and primary angioplasty.
    Goldman L
    J Am Coll Cardiol; 1995 Jun; 25(7 Suppl):38S-41S. PubMed ID: 7775713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary angioplasty versus intravenous thrombolysis for acute myocardial infarction.
    Cucherat M; Bonnefoy E; Tremeau G
    Cochrane Database Syst Rev; 2000; (2):CD001560. PubMed ID: 10796812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biases in Individualized Cost-effectiveness Analysis: Influence of Choices in Modeling Short-Term, Trial-Based, Mortality Risk Reduction and Post-Trial Life Expectancy.
    van Klaveren D; Wong JB; Kent DM; Steyerberg EW
    Med Decis Making; 2017 Oct; 37(7):770-778. PubMed ID: 28854143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of reperfusion regimens with or without tirofiban in ST-elevation acute myocardial infarction.
    Martínez-Ríos MA; Rosas M; González H; Peña-Duque MA; Martínez-Sánchez C; Gaspar J; García H; Gaxiola E; Delgado L; Carrillo J; Leyva JL; Lupi E;
    Am J Cardiol; 2004 Feb; 93(3):280-7. PubMed ID: 14759375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute myocardial infarction: immediate coronary angioplasty for failure or contra-indications of thrombolytic therapy. Apropos of a series of 100 cases].
    Mossard JM; Arbogast R; Roman S; Baruthio J; Germain P; Roul G; Kraenner C; Bareiss P; Sacrez A
    Arch Mal Coeur Vaiss; 1991 Apr; 84(4):469-75. PubMed ID: 1905914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-utility analysis of thrombolytic therapy.
    Simoons ML; Vos J; Martens LL
    Eur Heart J; 1991 Jun; 12(6):694-9. PubMed ID: 1907241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.